Portal:Disease/BlauBookPathways
From WikiPathways
(Difference between revisions)
Line 1: | Line 1: | ||
- | * [[Pathway:WP4156]] - Chapter 1 " | + | * [[Pathway:WP4156]] - Chapter 1 "Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism" |
- | + | * [[Pathway:WP4259]] - Chapter 10 "Disorders of Folate Metabolism and Transport" | |
- | * [[Pathway:WP4259]] - Chapter | + | * [[Pathway:WP4288]] - Chapter 10 "MTHFR deficiency (additonal pathway)" |
- | * [[Pathway:WP4288]] - Chapter | + | |
+ | * [[Pathway:WP4228]] - Chapter 11 "Vitamine B6-Dependent and Responsive Disorders" | ||
+ | * [[Pathway:WP4292]] - Chapter 12 "Methionine metabolism" | ||
* [[Pathway:WP4271]] - Chapter 13 "Vitamin B12 Disorders" | * [[Pathway:WP4271]] - Chapter 13 "Vitamin B12 Disorders" | ||
* [[Pathway:WP4297]] - Chapter 15 "Thiamine Disorders" | * [[Pathway:WP4297]] - Chapter 15 "Thiamine Disorders" | ||
- | * [[Pathway:WP4236]] - Chapter 20 "Disorders of the Krebs | + | * [[Pathway:WP4236]] - Chapter 20 "Disorders of the Krebs Cycle" |
* [[Pathway:WP4153]] - Chapter 25 "Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses" | * [[Pathway:WP4153]] - Chapter 25 "Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses" | ||
* [[Pathway:WP4220]] - Chapter 31 "Neurotransmitter Disorders" | * [[Pathway:WP4220]] - Chapter 31 "Neurotransmitter Disorders" | ||
- | * [[Pathway:WP4224]] - Chapter 41 "Purine | + | * [[Pathway:WP4224]] - Chapter 41 "Purine Disorders" |
- | * [[Pathway:WP4225]] - Chapter 41 "Pyrimidine | + | * [[Pathway:WP4225]] - Chapter 41 "Pyrimidine Disorders" |
- | + | ||
- | + | ||
- | + |
Revision as of 13:38, 21 January 2019
- Pathway:WP4156 - Chapter 1 "Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism"
- Pathway:WP4259 - Chapter 10 "Disorders of Folate Metabolism and Transport"
- Pathway:WP4288 - Chapter 10 "MTHFR deficiency (additonal pathway)"
- Pathway:WP4228 - Chapter 11 "Vitamine B6-Dependent and Responsive Disorders"
- Pathway:WP4292 - Chapter 12 "Methionine metabolism"
- Pathway:WP4271 - Chapter 13 "Vitamin B12 Disorders"
- Pathway:WP4297 - Chapter 15 "Thiamine Disorders"
- Pathway:WP4236 - Chapter 20 "Disorders of the Krebs Cycle"
- Pathway:WP4153 - Chapter 25 "Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses"
- Pathway:WP4220 - Chapter 31 "Neurotransmitter Disorders"
- Pathway:WP4224 - Chapter 41 "Purine Disorders"
- Pathway:WP4225 - Chapter 41 "Pyrimidine Disorders"